Literature DB >> 7536171

Comparison of mRNA contents of interleukin-1 beta and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice.

M Welsh1, N Welsh, K Bendtzen, J Mares, E Strandell, C Oberg, S Sandler.   

Abstract

Interleukin-1 beta (IL-1 beta) has been suggested to mediate beta-cell destruction in insulin-dependent diabetes mellitus (IDDM) by inducing nitric oxide production. In this study, we assessed the levels of IL-1 beta and the inducible form of nitric oxide synthase (iNOS), using a semi-quantitative polymerase chain reaction assay, and performed determinations of nitrite accumulation and IL-1 beta bioactivity, on pancreatic islets isolated from 5- and 16-week-old female and male nonobese diabetic (NOD) mice and from nondiabetes prone NMRI mice. NOD mouse islets contained notable amounts of IL-1 beta mRNA. At 5 weeks of age, but not at 16 weeks, the values were higher in islets isolated from NOD females compared to males. The IL-1 beta bioactivity showed differences roughly reflecting the mRNA levels in the NOD mouse islets. In the NMRI mouse islets the IL-1 beta bioactivity was very low. The expression of iNOS mRNA increased in both male and female islets between 5 and 16 weeks of age. Immunocytochemistry of pancreatic sections indicated the presence of macrophages especially in the peri-insular area of the NOD mice which suggests that IL-1 beta was produced by macrophages. The levels of IL-1 beta activity and mRNA in freshly isolated islets from NOD 5-weeks-old females did not correlate to the iNOS mRNA content or to the nitrite production. However, after incubation with IL-1 beta in vitro, both NOD and NMRI islets responded with a marked increase in nitric oxide production.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536171     DOI: 10.1007/bf00400089

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  53 in total

Review 1.  Biochemical and molecular actions of interleukin-1 on pancreatic beta-cells.

Authors:  S Sandler; D L Eizirik; C Svensson; E Strandell; M Welsh; N Welsh
Journal:  Autoimmunity       Date:  1991       Impact factor: 2.815

2.  In situ analysis of pancreatic islets in rats developing diabetes. Appearance of nonendocrine cells with surface MHC class II antigens and cytoplasmic insulin immunoreactivity.

Authors:  P A In't Veld; D G Pipeleers
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

3.  Identification of the 37-kDa protein displaying a variable interaction with the erythroid cell membrane as glyceraldehyde-3-phosphate dehydrogenase.

Authors:  R W Allen; K A Trach; J A Hoch
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

4.  Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus.

Authors:  E Strandell; D L Eizirik; S Sandler
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

5.  Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats.

Authors:  R Kleemann; H Rothe; V Kolb-Bachofen; Q W Xie; C Nathan; S Martin; H Kolb
Journal:  FEBS Lett       Date:  1993-08-09       Impact factor: 4.124

6.  Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.

Authors:  J A Corbett; J L Wang; M A Sweetland; J R Lancaster; M L McDaniel
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

7.  Interleukin-1 beta induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages.

Authors:  D L Eizirik; E Cagliero; A Björklund; N Welsh
Journal:  FEBS Lett       Date:  1992-08-24       Impact factor: 4.124

8.  Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process.

Authors:  J A Corbett; A Mikhael; J Shimizu; K Frederick; T P Misko; M L McDaniel; O Kanagawa; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

9.  Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.

Authors:  D L Kaufman; M Clare-Salzler; J Tian; T Forsthuber; G S Ting; P Robinson; M A Atkinson; E E Sercarz; A J Tobin; P V Lehmann
Journal:  Nature       Date:  1993-11-04       Impact factor: 49.962

10.  Two interleukin 1 genes in the mouse: cloning and expression of the cDNA for murine interleukin 1 beta.

Authors:  P W Gray; D Glaister; E Chen; D V Goeddel; D Pennica
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

View more
  4 in total

Review 1.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

2.  Human pancreatic duct cells can produce tumour necrosis factor-alpha that damages neighbouring beta cells and activates dendritic cells.

Authors:  B Movahedi; M Van de Casteele; N Caluwé; G Stangé; K Breckpot; K Thielemans; G Vreugdenhil; C Mathieu; D Pipeleers
Journal:  Diabetologia       Date:  2004-06-08       Impact factor: 10.122

3.  Insulin-like growth factor-1 (IGF-1) protects NOD mice from insulitis and diabetes.

Authors:  I Bergerot; N Fabien; V Maguer; C Thivolet
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

4.  Effect of cyclosporin-A on the blood--retinal barrier permeability in streptozotocin-induced diabetes.

Authors:  A Carmo; J G Cunha-Vaz; A P Carvalho; M C Lopes
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.